Prognosis of a family with familial medullary thyroid carcinoma [1]

Journal of Experimental and Clinical Cancer Research

Volumn 18, Issue 2, 1999, Pages 223-224

  Takami, H ^a,b   Niimi, M ^a   Ikeda, Y ^a  

^a TEIKYO UNIVERSITY   (Japan)

^b TEIKYO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Familial medullary thyroid carcinoma; Inherited medullary thyroid carcinoma; Prognosis; RET proto oncogene

Indexed keywords

ADULT; AGED; CLINICAL ARTICLE; FAMILIAL CANCER; FAMILY STUDY; FEMALE; GENE MUTATION; HETEROZYGOTE DETECTION; HUMAN; LETTER; MALE; PEDIGREE; PRIORITY JOURNAL; PROGNOSIS; PROTO ONCOGENE; THYROID MEDULLARY CARCINOMA; THYROIDECTOMY;

ADULT; AGED; CARCINOMA, MEDULLARY; CHILD, PRESCHOOL; HUMANS; INFANT; MALE; MIDDLE AGED; PEDIGREE; PROGNOSIS; THYROID NEOPLASMS;

EID: 0032784985     PISSN: 03929078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (5)

1. Boccia L.M., Green J.S., Joyce C., Eng C., Taylor S.A.M., Mulligan L.M.: Mutation of RET codon 768 is associated with the FMTC phenotype. Clin. Genet. 51: 81-85. 1997.
2. Moley J.F.: Medullary thyroid carcinoma. In: Clark O.H., Duh Q-Y., eds. Textbook of Endocrine Surgery. Philadelphia: W. B. Saunders Co, 1997: 108-118.
3. Takami H. RET proto-oncogene mutation analysis for multiple endocrine neoplasia type 2. Arch. Surg. 133: 679. 1998.
4. Eng C., Clayton D., Schuffenecker I., et al.: The relationship between specific RET proto-oncogene mutations and disease phenotype in multiple endocrine neoplasia type 2: International RET mutation consortium analysis. JAMA. 276: 1575-1579. 1996.
5. Takami H., Thosen T., Shirahama S., Ogura K., Hikiji K.: Does the syndrome of familial medullary thyroid carcinoma describe a distinct clinical entity? Eur. J. Cancer. 34: 1639-1640. 1998.